Collaborative multidisciplinary workshop report: Clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease

Henry Rosen, Joseph B. Muhlestein, John Bartlett, Shaw Chen, Gary Chikami, Marshall Corson, P. K. Shah, Enrique Gurfinkel, Hunter Handsfield, Lisa Jackson, Charles Knirsch, Richard Kronmal, J. Allen McCutchan, Steven Shea

Research output: Contribution to journalArticle

Abstract

The task assigned to the working group on Clinical Antimicrobial Trials for Primary and/or Secondary Prevention of Atherosclerotic Cardiovascular Disease was to evaluate the need for additional clinical antibiotic trials of a primary or secondary nature for the treatment of atherosclerotic heart disease and to suggest possible designs for future trials. In addition, the working group was to define the role of collaboration in answering research questions.

Original languageEnglish (US)
Pages (from-to)S582-S584
JournalJournal of Infectious Diseases
Volume181
Issue number6 SUPPL. 3
StatePublished - Jul 10 2000

    Fingerprint

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Rosen, H., Muhlestein, J. B., Bartlett, J., Chen, S., Chikami, G., Corson, M., Shah, P. K., Gurfinkel, E., Handsfield, H., Jackson, L., Knirsch, C., Kronmal, R., McCutchan, J. A., & Shea, S. (2000). Collaborative multidisciplinary workshop report: Clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease. Journal of Infectious Diseases, 181(6 SUPPL. 3), S582-S584.